Gladstone Institutional Advisory LLC Biogen Inc. Transaction History

Gladstone Institutional Advisory LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$222.59 - $267.94 $213,908 - $257,490	961 New	961 $248,000
Q4 2021 Feb 11, 2022	SELL	$223.92 - $287.77 $289,976 - $372,662	-1,295 Closed	0 $0
Q3 2021 Jan 27, 2023	SELL	$282.99 - $369.05 $198,658 - $259,073	-702 Reduced 35.15%	1,295 $366,000
Q3 2021 Nov 15, 2021	SELL	$282.99 - $369.05 $198,658 - $259,073	-702 Reduced 35.15%	1,295 $366,000
Q2 2021 Jan 27, 2023	BUY	$259.0 - $414.71 $517,223 - $828,175	1,997 New	1,997 $692,000
Q2 2021 Aug 13, 2021	BUY	$259.0 - $414.71 $517,223 - $828,175	1,997 New	1,997 $692,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Gladstone Institutional Advisory LLC, based on Form 13F filings with the SEC.

Stay updated on Gladstone Institutional Advisory LLC with notifications on news.